New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients.

MedStar author(s):
Citation: Cardiovascular Drugs & Therapy. 29(1):1-3, 2015 Feb.PMID: 25702643Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: *ATP Binding Cassette Transporter 1/me [Metabolism] | *Cholesterol/me [Metabolism] | *Hydroxymethylglutaryl-CoA Reductase Inhibitors/pd [Pharmacology] | *Lipoproteins, HDL/me [Metabolism] | *MicroRNAs/me [Metabolism] | *Simvastatin/pd [Pharmacology] | Animals | HumansYear: 2015ISSN:
  • 1573-7241
Name of journal: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular PharmacotherapyAll authors: Brewer HB Jr, Rosenson RSFiscal year: FY2015Digital Object Identifier: Date added to catalog: 2016-01-15
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 25702643 Available 25702643

English

Powered by Koha